title: Surgery for small cell lung cancer.
abstract: Small-cell lung cancer (SCLC) comprises approximately 14% of all lung cancer cases. Most patients present with locally advanced or metastatic disease and are therefore treated nonoperatively with chemotherapy, radiotherapy, or both. A small subset of patients with SCLC present with early-stage disease and will benefit from surgical resection plus chemotherapy. The rationale for radiotherapy in these patients remains controversial.
authors.affiliation: Division of Thoracic Surgery, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 676 North Saint Clair Street, Suite 650, Chicago, IL 60611, USA.
authors.forename: Alberto
authors.initials: A
authors.lastname: de Hoyos
authors.affiliation: Division of Thoracic Surgery, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 676 North Saint Clair Street, Suite 650, Chicago, IL 60611, USA. Electronic address: mdecamp@nmh.org.
authors.forename: Malcolm M
authors.initials: MM
authors.lastname: DeCamp
mesh_terms: D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods*; D055752:Small Cell Lung Carcinoma / Q000473:pathology / Q000601:surgery*
keywords: Early-stage small cell lung cancer; Lobectomy; Lung resection; Small cell lung cancer